tm logo

Monitor this mark

View On USPTO

XENAZINE
Live/Registered
REGISTERED AND RENEWED

on 15 Jun 2024

Last Applicant/ Owned by

BAUSCH HEALTH IRELAND LIMITED

Citywest Business Campus

DUBLIN

IE

24

Serial Number

76181171 filed on 13th Dec 2000

Registration Number

2839404 registered on 11th May 2004

in the Principal Register

Correspondent Address

Jeremy Blackowicz

Jeremy Blackowicz Bausch Health Companies

Bridgewater, NJ 08807

United States

Filing Basis

1. intent to use

Disclaimer

NO DATA

XENAZINE

Pharmaceutical preparations, namely for the treatment of hyperkinetic movement disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations, namely for the treatment of hyperkinetic movement disorders

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 76181171

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
15th Jun 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
15th Jun 2024REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
15th Jun 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
15th Jun 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
14th Mar 2024TEAS SECTION 8 & 9 RECEIVED
11th May 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08th Feb 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
18th Jan 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
28th Dec 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
14th Dec 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY